vs
Moolec Science SA（MLEC）与Nomad Foods Ltd（NOMD）财务数据对比。点击上方公司名可切换其他公司
Nomad Foods Ltd的季度营收约是Moolec Science SA的315.9倍（$834.9M vs $2.6M）
Moolec Science SA是一家专注于分子农业的农业生物技术与食品科技企业，通过改造作物平台生产可持续、高性价比的动物源蛋白，可应用于人造肉、乳制品及食品配料领域，服务全球多地的食品生产商与消费品品牌。
游牧食品（Nomad Foods）是欧洲最大的冷冻食品企业，总部位于英国，业务覆盖22个欧洲市场，从事冷冻食品的生产、销售与配送工作。旗下拥有Birds Eye、Ledo、Iglo、Findus、Frikom等知名品牌，核心产品包括鱼条、奶油菠菜、豌豆、鸡肉类冷冻食品，在纽交所上市，股票代码为NOMD。
MLEC vs NOMD — 直观对比
营收规模更大
NOMD
是对方的315.9倍
$2.6M
损益表 — Q2 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.6M | $834.9M |
| 净利润 | $-2.4M | — |
| 毛利率 | -25.5% | 25.6% |
| 营业利润率 | -77.9% | 9.1% |
| 净利率 | -91.8% | — |
| 营收同比 | — | -2.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLECNOMD
| Q4 25 | — | $834.9M | ||
| Q4 24 | $2.6M | $856.9M | ||
| Q4 23 | — | $821.7M | ||
| Q3 23 | $1.7M | — | ||
| Q4 22 | — | $810.2M |
净利润MLECNOMD
| Q4 25 | — | — | ||
| Q4 24 | $-2.4M | $55.5M | ||
| Q4 23 | — | $26.7M | ||
| Q3 23 | $-1.6M | — | ||
| Q4 22 | — | $40.1M |
毛利率MLECNOMD
| Q4 25 | — | 25.6% | ||
| Q4 24 | -25.5% | 28.5% | ||
| Q4 23 | — | 27.3% | ||
| Q3 23 | 12.7% | — | ||
| Q4 22 | — | 25.7% |
营业利润率MLECNOMD
| Q4 25 | — | 9.1% | ||
| Q4 24 | -77.9% | 11.5% | ||
| Q4 23 | — | 8.8% | ||
| Q3 23 | -130.3% | — | ||
| Q4 22 | — | 8.7% |
净利率MLECNOMD
| Q4 25 | — | — | ||
| Q4 24 | -91.8% | 6.5% | ||
| Q4 23 | — | 3.2% | ||
| Q3 23 | -91.4% | — | ||
| Q4 22 | — | 4.9% |
每股收益（稀释后）MLECNOMD
| Q4 25 | — | — | ||
| Q4 24 | $-0.06 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-0.04 | — | ||
| Q4 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | — |
| 总债务越低越好 | — | $2.5B |
| 股东权益账面价值 | $2.8M | $2.7B |
| 总资产 | $31.4M | $6.8B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MLECNOMD
| Q4 25 | — | — | ||
| Q4 24 | $1.9M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $853.6K | — | ||
| Q4 22 | — | $399.0M |
总债务MLECNOMD
| Q4 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q4 23 | — | $2.3B | ||
| Q3 23 | — | — | ||
| Q4 22 | — | $2.3B |
股东权益MLECNOMD
| Q4 25 | — | $2.7B | ||
| Q4 24 | $2.8M | $2.9B | ||
| Q4 23 | — | $2.8B | ||
| Q3 23 | $8.9M | — | ||
| Q4 22 | — | $2.8B |
总资产MLECNOMD
| Q4 25 | — | $6.8B | ||
| Q4 24 | $31.4M | $6.9B | ||
| Q4 23 | — | $6.9B | ||
| Q3 23 | $22.5M | — | ||
| Q4 22 | — | $6.8B |
负债/权益比MLECNOMD
| Q4 25 | — | 0.92× | ||
| Q4 24 | — | 0.82× | ||
| Q4 23 | — | 0.82× | ||
| Q3 23 | — | — | ||
| Q4 22 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $357.2M |
| 自由现金流经营现金流 - 资本支出 | — | $272.4M |
| 自由现金流率自由现金流/营收 | — | 32.6% |
| 资本支出强度资本支出/营收 | 4.4% | 10.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $1.3B |
8季度趋势，按日历期对齐
经营现金流MLECNOMD
| Q4 25 | — | $357.2M | ||
| Q4 24 | — | $470.2M | ||
| Q4 23 | — | $465.3M | ||
| Q3 23 | $-1.7M | — | ||
| Q4 22 | — | $328.1M |
自由现金流MLECNOMD
| Q4 25 | — | $272.4M | ||
| Q4 24 | — | $383.5M | ||
| Q4 23 | — | $376.3M | ||
| Q3 23 | $-1.8M | — | ||
| Q4 22 | — | $242.7M |
自由现金流率MLECNOMD
| Q4 25 | — | 32.6% | ||
| Q4 24 | — | 44.8% | ||
| Q4 23 | — | 45.8% | ||
| Q3 23 | -106.2% | — | ||
| Q4 22 | — | 30.0% |
资本支出强度MLECNOMD
| Q4 25 | — | 10.2% | ||
| Q4 24 | 4.4% | 10.1% | ||
| Q4 23 | — | 10.8% | ||
| Q3 23 | 6.0% | — | ||
| Q4 22 | — | 10.5% |
现金转化率MLECNOMD
| Q4 25 | — | — | ||
| Q4 24 | — | 8.47× | ||
| Q4 23 | — | 17.44× | ||
| Q3 23 | — | — | ||
| Q4 22 | — | 8.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
